| Company Name: |
BOC Sciences |
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
| Company Name: |
cjbscvictory |
| Tel: |
13348960310 13348960310 |
| Email: |
3003867561@qq.com |
KRAS G12C inhibitor 13 manufacturers
|
| | KRAS G12C inhibitor 13 Basic information |
| Product Name: | KRAS G12C inhibitor 13 | | Synonyms: | KRAS G12C inhibitor 13;2-Propen-1-one, 1-[7-[6-ethenyl-7-(5-methyl-1H-indazol-4-yl)-2-[[1-(tetrahydro-2H-pyran-4-yl)-4-piperidinyl]oxy]-8-(2,2,2-trifluoroethoxy)-4-quinazolinyl]-2,7-diazaspiro[3.5]non-2-yl]-;KRAS G12C inhibitor 13,KRAS G-12C inhibitor 13 | | CAS: | 2241719-75-3 | | MF: | C40H46F3N7O4 | | MW: | 745.83 | | EINECS: | | | Product Categories: | | | Mol File: | 2241719-75-3.mol |  |
| | KRAS G12C inhibitor 13 Chemical Properties |
| Boiling point | 876.6±75.0 °C(Predicted) | | density | 1.37±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | Soluble in DMSO | | pka | 12.18±0.40(Predicted) |
| | KRAS G12C inhibitor 13 Usage And Synthesis |
| Uses | KRAS G12C inhibitor 13 is a KRAS G12C inhibitor extracted from patent WO2018143315A1, compound 30[1]. | | IC 50 | KRas G12C | | References | [1] KURAMOTO, Kazuyuki, et al. Quinazoline compound. WO2018143315A1. |
| | KRAS G12C inhibitor 13 Preparation Products And Raw materials |
|
|
Tag:KRAS G12C inhibitor 13(2241719-75-3)
Related Product Information
|
|
2-Propen-1-one, 1-[(3S)-4-[(7R)-7-[6-amino-4-methyl-3-(trifluoromethyl)-2-pyridinyl]-6-chloro-8-fluoro-2-[[(2S)-1-methyl-2-pyrrolidinyl]methoxy]-4-quinazolinyl]-3-methyl-1-piperazinyl]-
2,7-Diazaspiro[4.4]nonane-2-acetamide, α-cyclopentyl-7-[[(2R,3R)-3-cyclopropyl-1-methyl-2-aziridinyl]carbonyl]-N-[(1R,10S,12S,18S)-1-[5-(4-cyclopropyl-1-piperazinyl)-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-2,7,8,10,11,12,13,16,17,18,19,21,22,23-tetradecahydro-22,22-dimethyl-13,19-dioxo-2-(2,2,2-trifluoroethyl)-15H-3,5-etheno-14,18-imino-6,10-methano-6H-pyrrolo[3,4-g][1,12,4,18]dioxadiazacyclodocosin-12-yl]-, (αS,5S)-
NAV2729
Y-27632
1,4-Oxazepin-5(2H)-one, 4-[3-[[2-[[2-ethyl-4-(4-methyl-1-piperazinyl)phenyl]amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]propyl]tetrahydro-
RMC-7977
|